Hydrochloric Acid

Hydrochloric Acid

SCHEMBL26645152

[Cl-].[H+].c1cc2n(n1)CCNC2

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 8/20 0.36
HTR2A P28223 7/20 0.36
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
ADRB2 P07550 1/20 0.34
NCF1 P14598 1/20 0.34
PLD1 Q13393 1/20 0.34
DRD2 P14416 3/20 0.34
DRD4 P21917 3/20 0.34
DRD3 P35462 3/20 0.34
HTR2B P41595 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL928542 0.98
Hydrochloric Acid SCHEMBL21814117 0.96 HTR2C (0.36) HTR2CHTR2APDCD1CD274ADRB2
Hydrochloric Acid SCHEMBL18704857 0.96 HTR2C (0.36) HTR2CHTR2APDCD1CD274ADRB2
Urea SCHEMBL21906544 0.88 PDCD1 (0.32) HTR2CHTR2APDCD1CD274ADRB2
SCHEMBL16102213 0.86 CHRNB2 (0.35) HTR2CHTR2ADRD2DRD4DRD3
Trifluoroacetic Acid SCHEMBL26645028 0.82 HRH4 (0.38) HTR2CHTR2APDCD1CD274HTR2B
SCHEMBL24722874 0.80 HTR2C (0.39) HTR2CHTR2AADRB2NCF1PLD1
SCHEMBL30295040 0.78
SCHEMBL21267039 0.77
SCHEMBL1680162 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed